PainReform Ltd. (PRFX)
NCM · Common · CUSIP M77798128
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PRFX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
M77798128 (prev. M77798102 )
IPO
9/1/2020 · $8.00/unit
Business: PainReform Ltd. is a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics. Its strategy is to incorporate generic drugs with our proprietary extended release drug-delivery system in order to create extended release drug products.

Company Contact

CEO
Ilan Hadar
CFO
Ehud Geller
Investor Relations
Crescendo Communications · 212-671-1020 · PRFX@crescendo-ir.com
SEC EDGAR Filings
View filings »